David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.28B |
| 2 |
Qualcomm
QCOM
|
+$1.99B |
| 3 |
TransDigm Group
TDG
|
+$1.4B |
| 4 |
Marvell Technology
MRVL
|
+$1.05B |
| 5 |
ASML
ASML
|
+$948M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 88.42% |
| 2 | Healthcare | 7.27% |
| 3 | Materials | 4.32% |
| 4 | Communication Services | 0% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
1
DELISTED
Altair Engineering Inc
ALTR
| $1.19B | 56.68% |
12,430,000
| – | – |
|
2
GlobalFoundries
GFS
$26.4B
| $665M | 31.74% |
16,514,952
-400,000
| -2% | -$18.6M |
|
3
Perimeter Solutions
PRM
$5.15B
| $90.5M | 4.32% |
6,725,000
-737,500
| -10% | -$7.64M |
|
4
Aura Biosciences
AURA
$809M
| $61.7M | 2.94% |
6,922,870
| – | – |
|
5
Zentalis Pharmaceuticals
ZNTL
$363M
| $51.4M | 2.45% |
13,959,973
| – | – |
|
|
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
| $35.8M | 1.71% |
37,681,515
-1,292,670
| -3% | -$1.47M |
|
7
Adaptive Biotechnologies
ADPT
$4.15B
| $3.33M | 0.16% |
650,000
-10,922,590
| -94% | -$47.6M |
|
8
Amazon
AMZN
$2.79T
| – | – |
-4,703,000
| Closed | -$909M |
|
|
ANSS
9
DELISTED
Ansys
ANSS
| – | – |
-323,778
| Closed | -$104M |
|
|
10
ASML
ASML
$677B
| – | – |
-927,200
| Closed | -$948M |
|
11
BridgeBio Pharma
BBIO
$15.9B
| – | – |
-240,000
| Closed | -$6.08M |
|
12
Geron
GERN
$977M
| – | – |
-571,500
| Closed | -$2.42M |
|
13
Alphabet (Google) Class A
GOOGL
$4.22T
| – | – |
-500,000
| Closed | -$91.1M |
|
|
14
Marvell Technology
MRVL
$213B
| – | – |
-15,055,500
| Closed | -$1.05B |
|
|
15
NVIDIA
NVDA
$5.2T
| – | – |
-26,585,120
| Closed | -$3.28B |
|
16
Okta
OKTA
$23.5B
| – | – |
-575,000
| Closed | -$53.8M |
|
|
17
Qualcomm
QCOM
$169B
| – | – |
-10,000,000
| Closed | -$1.99B |
|
18
Synopsys
SNPS
$76.2B
| – | – |
-717,735
| Closed | -$427M |
|
|
19
TransDigm Group
TDG
$66.4B
| – | – |
-1,094,900
| Closed | -$1.4B |
|
20
Unity
U
$20.7B
| – | – |
-250,000
| Closed | -$4.07M |
|
21
Veeva Systems
VEEV
$40.3B
| – | – |
-748,821
| Closed | -$137M |
|
22
Workday
WDAY
$49.4B
| – | – |
-1,586,043
| Closed | -$355M |
|
23
Zscaler
ZS
$29.4B
| – | – |
-261,405
| Closed | -$50.2M |
|
Similar funds
David Goel's Q3 2024 Portfolio in Review
As of Q3 2024, David Goel held 23 positions worth $2.09B, down 84% from $13.1B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
David Goel withdrew a net $10.9B in Q3 2024, closing 16 positions and reducing 4 holdings. Its most notable exit was NVIDIA, an estimated $3.28B position sold in full.
By sector, the portfolio is most concentrated in Technology at 88% of assets, up from 79% a quarter earlier, followed by Healthcare and Materials.
- David Goel's biggest Q3 2024 reduction was Adaptive Biotechnologies, cutting an estimated $47.6M.
- David Goel fully exited NVIDIA in Q3 2024, selling an estimated $3.28B.
- David Goel's ten largest holdings make up 100% of its $2.09B portfolio in Q3 2024.
- David Goel opened 0 new positions and closed 16 in Q3 2024.
- David Goel's portfolio value fell 84% quarter-over-quarter to $2.09B.
Based on Matrix Capital Management Company's 13F filing for Q3 2024, filed 14 Nov 2024.